Bill Miller’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-278,655
Closed -$40.8M 115
2019
Q1
$40.8M Sell
278,655
-320
-0.1% -$46.4K 1.62% 27
2018
Q4
$37.3M Sell
278,975
-280
-0.1% -$45.9K 1.69% 27
2018
Q3
$53.2M Buy
279,255
+7,765
+3% +$1.43M 1.72% 29
2018
Q2
$45.3M Sell
271,490
-320
-0.1% -$51.4K 1.69% 30
2018
Q1
$45.7M Buy
271,810
+112,685
+71% +$18.9M 1.91% 23
2017
Q4
$26M Sell
159,125
-2,350
-1% -$422K 1.11% 30
2017
Q3
$33.1M Sell
161,475
-3,650
-2% -$849K 1.42% 27
2017
Q2
$40.1M Sell
165,125
-5,600
-3% -$1.32M 1.63% 24
2017
Q1
$40.8M Buy
170,725
+37,710
+28% +$8.78M 1.79% 24
2016
Q4
$27.9M Buy
+133,015
New +$27.6M 1.23% 29

Other funds holding AGN

Bill Miller's AGN Position: Q2 2019 in Review

Bill Miller sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 278,655 shares — an estimated $40.8M sold.

Bill Miller first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $53.2M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Bill Miller reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Bill Miller sold 278,655 Allergan plc shares in Q2 2019, an estimated $40.8M.
  • Bill Miller first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Bill Miller's Allergan plc position peaked at $53.2M in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Miller Value Partners's 13F filing for Q2 2019, filed 14 Aug 2019.